Business Description
BrainsWay Ltd
ISIN : IL0011007189
Description
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 102.18 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.12 | |||||
| Interest Coverage | 1.27 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 3.37 | |||||
| Beneish M-Score | -2.7 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.8 | |||||
| 3-Year EBITDA Growth Rate | 20.6 | |||||
| 3-Year EPS without NRI Growth Rate | 20.6 | |||||
| 3-Year FCF Growth Rate | 42.3 | |||||
| 3-Year Book Growth Rate | 12.3 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 24.41 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 100 | |||||
| 9-Day RSI | 99.99 | |||||
| 14-Day RSI | 99.79 | |||||
| 3-1 Month Momentum % | 50 | |||||
| 6-1 Month Momentum % | 50 | |||||
| 12-1 Month Momentum % | 65.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.52 | |||||
| Quick Ratio | 4.23 | |||||
| Cash Ratio | 3.79 | |||||
| Days Inventory | 137.56 | |||||
| Days Sales Outstanding | 35.76 | |||||
| Days Payable | 37.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -14.3 | |||||
| Shareholder Yield % | 0.01 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 74.58 | |||||
| Operating Margin % | 2.96 | |||||
| Net Margin % | 3.88 | |||||
| FCF Margin % | 15.44 | |||||
| ROE % | 3.54 | |||||
| ROA % | 2.3 | |||||
| ROIC % | 7.01 | |||||
| 3-Year ROIIC % | 61.38 | |||||
| ROC (Joel Greenblatt) % | 35.59 | |||||
| ROCE % | 4.79 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 102.88 | |||||
| Forward PE Ratio | 24.61 | |||||
| PE Ratio without NRI | 102.88 | |||||
| Price-to-Owner-Earnings | 44.85 | |||||
| PEG Ratio | 5.81 | |||||
| PS Ratio | 4.06 | |||||
| PB Ratio | 3.69 | |||||
| Price-to-Tangible-Book | 3.71 | |||||
| Price-to-Free-Cash-Flow | 26.78 | |||||
| Price-to-Operating-Cash-Flow | 17.1 | |||||
| EV-to-EBIT | 53.22 | |||||
| EV-to-EBITDA | 34.52 | |||||
| EV-to-Revenue | 3.57 | |||||
| EV-to-Forward-Revenue | 3.04 | |||||
| EV-to-FCF | 23.09 | |||||
| Price-to-GF-Value | 1.32 | |||||
| Price-to-Median-PS-Value | 0.92 | |||||
| Price-to-Graham-Number | 4.09 | |||||
| Price-to-Net-Current-Asset-Value | 5.53 | |||||
| Price-to-Net-Cash | 8.08 | |||||
| Earnings Yield (Greenblatt) % | 1.88 | |||||
| FCF Yield % | 3.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BRSYF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
BrainsWay Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 38.631 | ||
| EPS (TTM) ($) | 0.047 | ||
| Beta | 27.65 | ||
| 3-Year Sharpe Ratio | 0.58 | ||
| 3-Year Sortino Ratio | 30.41 | ||
| Volatility % | 61.73 | ||
| 14-Day RSI | 99.79 | ||
| 14-Day ATR ($) | 0.000881 | ||
| 20-Day SMA ($) | 3.15 | ||
| 12-1 Month Momentum % | 65.79 | ||
| 52-Week Range ($) | 1.85 - 3.15 | ||
| Shares Outstanding (Mil) | 37.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BrainsWay Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BrainsWay Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
BrainsWay Ltd Frequently Asked Questions
What is BrainsWay Ltd(BRSYF)'s stock price today?
The current price of BRSYF is $3.15. The 52 week high of BRSYF is $3.15 and 52 week low is $1.85.
When is next earnings date of BrainsWay Ltd(BRSYF)?
The next earnings date of BrainsWay Ltd(BRSYF) is 2025-03-06 Est..
Does BrainsWay Ltd(BRSYF) pay dividends? If so, how much?
BrainsWay Ltd(BRSYF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers